# Natco Pharma Limited – FDA Inspection, Feb 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/67af5a38-d989-41ea-9c1c-d6542387459a
Source feed: FDA_Inspections

> FDA inspection 1198251 of Natco Pharma Limited, February 03, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198251
- Company Name: Natco Pharma Limited
- Inspection Date: 2023-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1331920 - 2026-08-21](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/b15c6908-585a-4b13-977b-36df87c1ddcd)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)

Company: https://www.keypedia.com/companies/natco-pharma-limited/2684a2f8-36c9-4d09-8a48-2c7f17e0ac7d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
